The open-cell vs closed-cell stent design distinction refers to how the individual struts and connecting bridges of a coronary stent are structured, which in turn influences flexibility, scaffolding uniformity, and side-branch accessibility. Both geometries are represented among contemporary stent platforms. This overview summarizes general engineering and clinical considerations for interventional cardiology teams; specific design selection remains a device- and case-specific decision.
What Defines an Open-Cell Design?
In an open-cell stent, not every strut intersection is connected by a bridging element, leaving some cells "open" along the stent's length.
- Generally offers greater flexibility, which can support deliverability through tortuous or angulated coronary anatomy
- Tends to allow easier access to side branches, since open segments can accommodate wire or balloon passage into a branching vessel without as much strut interference
- The INVAMED ATLAS drug-eluting coronary stent platform uses an open-cell design paired with a laser-cut cobalt-chromium L605 frame
- May exhibit somewhat more variable scaffolding uniformity across the stented segment compared to closed-cell geometry, particularly around curves
What Defines a Closed-Cell Design?
In a closed-cell stent, every strut intersection is connected by a bridging element, creating a more uniform, consistently connected cell pattern along the entire stent length.
- Generally provides more uniform scaffolding and vessel wall coverage
- Tends to be less flexible than open-cell designs, which can affect deliverability in highly tortuous segments
- May offer more consistent radial force distribution along the stent length
- Historically associated with more predictable foreshortening behavior during deployment in some platform comparisons
How Do the Two Geometries Compare?
| Characteristic | Open-Cell | Closed-Cell |
|---|---|---|
| Flexibility | Generally higher | Generally lower |
| Side-branch access | Generally easier | More variable |
| Scaffolding uniformity | More variable | Generally more uniform |
| Deliverability in tortuous vessels | Often favored | May be more challenging |
| Common pairing | Frequently used in DES platforms favoring conformability | Used across various BMS and DES platforms |
These are general design tendencies; actual clinical performance also depends on strut thickness, alloy, drug coating, and lesion-specific factors.
How Does Cell Geometry Factor Into Clinical Decision-Making?
Operators may weigh cell geometry alongside other stent characteristics, such as alloy composition, strut thickness, and drug elution profile, when selecting a platform for a specific lesion. Complex or tortuous anatomy, and lesions near a side branch, may favor consideration of an open-cell platform's conformability, while operators prioritizing maximal uniform scaffolding in a relatively straight segment may weigh closed-cell characteristics differently. As with all device selection, this remains within the clinical judgment of the treating interventional cardiologist and is guided by the specific device's Instructions for Use.
Frequently Asked Questions
Does cell design affect restenosis rates independently of drug coating?
Cell geometry is generally considered a secondary factor compared to drug elution and strut thickness when it comes to restenosis risk, though scaffolding uniformity may play some role. Available comparative evidence should be reviewed in context with the specific platforms being compared.
Is open-cell design always preferred for tortuous vessels?
Open-cell platforms are frequently favored for their flexibility in tortuous anatomy, but operator experience, specific lesion characteristics, and the overall device profile (strut thickness, alloy, coating) also factor into platform selection.
Can cell geometry affect how a stent appears on follow-up imaging?
Cell geometry itself does not significantly affect radiopacity, which is primarily governed by the alloy and any radiopaque markers (such as platinum-iridium markers used on some platforms). However, geometry can influence how uniformly the stent conforms to vessel curvature, which may be visually apparent on follow-up angiography.
Related INVAMED Resources
- ATLAS Drug Eluting Coronary Stent System Cobalt Chromium
- A Clinician's Guide to Coronary Stent Sizing
- Coronary Artery Disease & Cardiac Interventions
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.